Adjuvant therapy for early breast cancer: where do we stand today?
Academic Article
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
publication date
- June 18, 2003
has subject area
- Antibodies, Monoclonal (MeSH)
- Antibodies, Monoclonal, Humanized (MeSH)
- Antineoplastic Agents (MeSH)
- Breast Neoplasms (MeSH)
- Chemotherapy, Adjuvant (MeSH)
- Drug Administration Schedule (MeSH)
- Drug Resistance, Neoplasm (MeSH)
- ErbB Receptors (MeSH)
- Female (MeSH)
- Humans (MeSH)
- Neoplasm Staging (MeSH)
- Oncogene Proteins v-erbB (MeSH)
- Risk Factors (MeSH)
- Trastuzumab (MeSH)
published in
- Medscape journal of medicine Journal